NEW YORK, Oct. 28 (GenomeWeb News) - Benitec said today that it has granted a worldwide non-exclusive license to Artemis Pharmaceuticals for use of its proprietary ddRNAi technology in transgenic mouse and rat model development.
Registering provides access to this and other free content.
Already have an account?Login Now.
The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.
A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.
The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.
In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.